MoneyWorks4Me

Camlin Fine Sciences - Quaterly Results

12 Aug 2026 Evaluate
The revenue zoomed 16.22% to Rs. 2224.86 millions for the quarter ended June 2026 as compared to Rs. 1914.38 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2026 is Rs. -123.12 millions as compared to Net Loss of Rs. -106.81 millions of corresponding quarter ended June 2025The Operating Profit of the company witnessed a decrease to 82.22 millions from 83.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2224.86 1914.38 16.22 2224.86 1914.38 16.22 8379.18 8864.91 -5.48
Other Income 14.02 36.89 -62.00 14.02 36.89 -62.00 349.51 206.15 69.54
PBIDT 82.22 83.70 -1.77 82.22 83.70 -1.77 828.40 912.18 -9.18
Interest 133.82 113.44 17.97 133.82 113.44 17.97 669.87 661.19 1.31
PBDT -51.60 -29.74 73.50 -51.60 -29.74 73.50 -4.17 -709.03 -99.41
Depreciation 135.12 134.03 0.81 135.12 134.03 0.81 536.77 525.27 2.19
PBT -186.72 -163.77 14.01 -186.72 -163.77 14.01 -540.94 -1234.30 -56.17
TAX -63.60 -56.96 11.66 -63.60 -56.96 11.66 -211.26 -471.20 -55.17
Deferred Tax -63.60 -56.96 11.66 -63.60 -56.96 11.66 -211.26 -487.80 -56.69
PAT -123.12 -106.81 15.27 -123.12 -106.81 15.27 -329.68 -763.10 -56.80
Equity 192.10 187.92 2.22 192.10 187.92 2.22 192.09 187.92 2.22
PBIDTM(%) 3.70 4.37 -15.48 3.70 4.37 -15.48 9.89 10.29 -3.92

Camlin Fine Sciences Share Price

103.70 -2.80 (-2.63%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2609.10
BASF India 4083.85
Pidilite Inds. 1690.00
Tata Chemicals 670.40
GNFC 568.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: